Skip to main content
Equibles

Quantinno Capital Management LP

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1759654 NEW YORK, NY
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,309,622
+$485,871 QoQ
Shares Held
642,486
+0.8% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 238 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Quantinno Capital Management LP holds $225,769,469 across 37 Drug Manufacturers - Specialty & Generic names. RDY ranks #10 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 1,974,908 $48,602,485
2 ZTS
Zoetis Inc.
 400,665 $28,791,786
3 TAK
Takeda Pharmaceutical Co Ltd
 1,402,650 $22,484,479
4 VTRS
Viatris Inc
 1,368,433 $21,730,716
5 UTHR
UNITED THERAPEUTICS Corp
 27,122 $14,695,513
6 PRGO
PERRIGO Co plc
 1,369,736 $14,231,557
7 NBIX
Neurocrine Biosciences Inc
 79,655 $13,425,053
8 HLN
Haleon plc
 1,151,189 $10,740,593

All Filings in RDY

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,309,622 642,486
2026-03-31 $8,823,751 637,094
2025-12-31 $5,226,221 372,238
2025-09-30 $4,454,727 318,650
2025-06-30 $3,532,711 235,044
2025-03-31 $1,609,918 122,056
2024-12-31 $1,692,514 107,189
2024-09-30 $1,607,829 20,237
2024-06-30 $1,306,125 17,143
2024-03-31 $899,050 12,257
2023-12-31 $641,666 9,222
2023-09-30 $467,086 6,985
2023-06-30 $383,203 6,072
2023-03-31 $291,026 5,112
2022-12-31 $487,950 9,429